Paper33355147
Swept-source OCTA quantification of capillary closure predicts ETDRS severity staging of NPDR.
Santos T and 9 others. Br J Ophthalmol, 2022. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Swept-source OCTA quantification of capillary closure predicts ETDRS severity staging of NPDR. Papers, record 33355147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33355147
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Swept-source OCTA quantification of capillary closure predicts ETDRS severity staging of NPDR.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Diabetic Retinopathy | Major topic |
| Fluorescein Angiography | |
| Fundus Oculi | |
| Humans | |
| Retinal Vessels | |
| Tomography, Optical Coherence |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32200833 | Grading Diabetic Retinopathy from Stereoscopic Color Fundus Photographs - An Extension of the Modified Airlie House Classification: ETDRS Report Number 10. | Ophthalmology | 2020 | https://conductscience.org/library/papers/32200833 | PubMed |
| 2 | 13129861 | Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. | Ophthalmology | 2003 | https://conductscience.org/library/papers/13129861 | PubMed |
| 3 | 30689991 | Earliest Evidence of Preclinical Diabetic Retinopathy Revealed Using Optical Coherence Tomography Angiography Perfused Capillary Density. | Am J Ophthalmol | 2019 | https://conductscience.org/library/papers/30689991 | PubMed |
| 4 | 16965491 | The relationships between risk factors and the distribution of retinopathy lesions in type 2 diabetes. | Acta Ophthalmol Scand | 2006 | https://conductscience.org/library/papers/16965491 | PubMed |
| 5 | 666982 | Pathophysiology of diabetic retinopathy. | Br J Ophthalmol | 1978 | https://conductscience.org/library/papers/666982 | PubMed |
| 6 | 6022598 | Studies on the effects of osmotically active substances on the circulation and structure of the retina. I. Observations in vivo. | Invest Ophthalmol | 1967 | https://conductscience.org/library/papers/6022598 | PubMed |
| 7 | 27927677 | Comparison of diabetic retinopathy classification using fluorescein angiography and optical coherence tomography angiography. | Br J Ophthalmol | 2017 | https://conductscience.org/library/papers/27927677 | PubMed |
| 8 | 32181799 | Characterization of Disease Progression in the Initial Stages of Retinopathy in Type 2 Diabetes: A 2-Year Longitudinal Study. | Invest Ophthalmol Vis Sci | 2020 | https://conductscience.org/library/papers/32181799 | PubMed |
| 9 | 30523027 | Multimodal Imaging of the Initial Stages of Diabetic Retinopathy: Different Disease Pathways in Different Patients. | Diabetes | 2019 | https://conductscience.org/library/papers/30523027 | PubMed |
| 10 | 5417650 | Simple diabetic retinopathy. Evolution of the lesions and therapeutic considerations. | Br J Ophthalmol | 1970 | https://conductscience.org/library/papers/5417650 | PubMed |
| 11 | 10512590 | Disturbed microvascular reactivity and shunting - a major cause for diabetic complications. | Vasc Med | 1999 | https://conductscience.org/library/papers/10512590 | PubMed |
| 12 | 32015239 | 19th EURETINA Congress Keynote Lecture: Diabetic Retinopathy Today. | Ophthalmologica | 2020 | https://conductscience.org/library/papers/32015239 | PubMed |
| 13 | 28301651 | Quantification of Retinal Microvascular Density in Optical Coherence Tomographic Angiography Images in Diabetic Retinopathy. | JAMA Ophthalmol | 2017 | https://conductscience.org/library/papers/28301651 | PubMed |
| 14 | 27205895 | CHARACTERIZATION OF THE MIDDLE CAPILLARY PLEXUS USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN HEALTHY AND DIABETIC EYES. | Retina | 2016 | https://conductscience.org/library/papers/27205895 | PubMed |
| 15 | 27557084 | ULTRAHIGH SPEED SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF RETINAL AND CHORIOCAPILLARIS ALTERATIONS IN DIABETIC PATIENTS WITH AND WITHOUT RETINOPATHY. | Retina | 2017 | https://conductscience.org/library/papers/27557084 | PubMed |
| 16 | 25104599 | Causes of vision loss worldwide, 1990-2010: a systematic analysis. | Lancet Glob Health | 2013 | https://conductscience.org/library/papers/25104599 | PubMed |
| 17 | 7611470 | Video microscopy of cerebrocortical capillary flow: response to hypotension and intracranial hypertension. | Am J Physiol | 1995 | https://conductscience.org/library/papers/7611470 | PubMed |
| 18 | 32408522 | Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy. | J Clin Med | 2020 | https://conductscience.org/library/papers/32408522 | PubMed |
| 19 | 30576300 | QUANTIFICATION OF RETINAL CAPILLARY NONPERFUSION IN DIABETICS USING WIDE-FIELD OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. | Retina | 2020 | https://conductscience.org/library/papers/30576300 | PubMed |
| 20 | 11594988 | The regional distribution of diabetic retinopathy lesions may reflect risk factors for progression of the disease. | Acta Ophthalmol Scand | 2001 | https://conductscience.org/library/papers/11594988 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42639252 | Association of Serum Meteorin-Like with OCTA Metrics in Type 2 Diabetic Nonproliferative Retinopathy: A Cross-Sectional Study. | Diabetes Metab Syndr Obes | 2026 | https://conductscience.org/library/papers/42639252 | PubMed |
| 41569021 | One-Year Progression of Capillary Nonperfusion in Nonproliferative Diabetic Retinopathy Using Noninvasive Imaging: The CHART Study. | Transl Vis Sci Technol | 2026 | https://conductscience.org/library/papers/41569021 | PubMed |
| 39639890 | Progression of Capillary Hypoperfusion in Advanced Stages of Nonproliferative Diabetic Retinopathy: 6-month Analysis of RICHARD Study. | Ophthalmol Sci | 2025 | https://conductscience.org/library/papers/39639890 | PubMed |
| 39578919 | Self-reported visual function and in-depth swept-source optical coherence tomography features of cystoid macular edema in retinitis pigmentosa. | Int J Retina Vitreous | 2024 | https://conductscience.org/library/papers/39578919 | PubMed |
| 38983076 | Advances in application of swept-source optical coherence tomography angiography in diagnosis and treatment of diabetic retinopathy. | Front Ophthalmol (Lausanne) | 2023 | https://conductscience.org/library/papers/38983076 | PubMed |
| 38780953 | Patterns of Progression of Nonproliferative Diabetic Retinopathy Using Non-Invasive Imaging. | Transl Vis Sci Technol | 2024 | https://conductscience.org/library/papers/38780953 | PubMed |
| 38337841 | Optical Coherence Tomography Angiography as a Diagnostic Tool for Diabetic Retinopathy. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/38337841 | PubMed |
| 37714881 | Synthetic OCT-A blood vessel maps using fundus images and generative adversarial networks. | Sci Rep | 2023 | https://conductscience.org/library/papers/37714881 | PubMed |
| 37280352 | Association of OCT and OCT angiography measures with the development and worsening of diabetic retinopathy in type 2 diabetes. | Eye (Lond) | 2023 | https://conductscience.org/library/papers/37280352 | PubMed |
| 36495395 | Different Risk Profiles for Progression of Nonproliferative Diabetic Retinopathy: A 2-Year Study. | Ophthalmol Ther | 2023 | https://conductscience.org/library/papers/36495395 | PubMed |
| 36494431 | Perspectives of diabetic retinopathy-challenges and opportunities. | Eye (Lond) | 2023 | https://conductscience.org/library/papers/36494431 | PubMed |
| 35158351 | Association between Neurodegeneration and Macular Perfusion in the Progression of Diabetic Retinopathy: A 3-Year Longitudinal Study. | Ophthalmologica | 2022 | https://conductscience.org/library/papers/35158351 | PubMed |
| 34916900 | Comparison of Different Metrics for the Identification of Vascular Changes in Diabetic Retinopathy Using OCTA. | Front Neurosci | 2021 | https://conductscience.org/library/papers/34916900 | PubMed |
| 34865186 | Characterization of One-Year Progression of Risk Phenotypes of Diabetic Retinopathy. | Ophthalmol Ther | 2022 | https://conductscience.org/library/papers/34865186 | PubMed |
| 34611239 | Volume rendered 3D OCTA assessment of macular ischemia in patients with type 1 diabetes and without diabetic retinopathy. | Sci Rep | 2021 | https://conductscience.org/library/papers/34611239 | PubMed |
| 34442470 | Characterization of Risk Profiles for Diabetic Retinopathy Progression. | J Pers Med | 2021 | https://conductscience.org/library/papers/34442470 | PubMed |
| 34070479 | Optical Coherence Tomography Angiography Metrics Monitor Severity Progression of Diabetic Retinopathy-3-Year Longitudinal Study. | J Clin Med | 2021 | https://conductscience.org/library/papers/34070479 | PubMed |
| 34063514 | Microaneurysm Turnover in Mild Non-Proliferative Diabetic Retinopathy is Associated with Progression and Development of Vision-Threatening Complications: A 5-Year Longitudinal Study. | J Clin Med | 2021 | https://conductscience.org/library/papers/34063514 | PubMed |
| 33922018 | A Central Role for Ischemia and OCTA Metrics to Follow DR Progression. | J Clin Med | 2021 | https://conductscience.org/library/papers/33922018 | PubMed |
| 33626529 | Looking Ahead: Visual and Anatomical Endpoints in Future Trials of Diabetic Macular Ischemia. | Ophthalmologica | 2021 | https://conductscience.org/library/papers/33626529 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33355147
GET https://conductscience.org/api/papers/v1/33355147/references?page=2